Dow Jones
37.976,78 -409,31 (-1,07%) Nasdaq
15.791,40 -191,69 (-1,20%) Nikkei 225
38.405,66 +470,90 (+1,24%) EUR/USD
1,0683 -0,0042 (-0,40%) Bitcoin EUR
58.726,11 -631,68 (-1,06%) CMC Crypto 200
1.290,32 -48,75 (-3,64%)
Aclarion, Inc. (ACON)
| Chiusura precedente | 0,2980 |
| Aperto | 0,3001 |
| Denaro | 0,2198 x 200 |
| Lettera | 0,3887 x 200 |
| Min-Max giorno | 0,2950 - 0,3178 |
| Intervallo di 52 settimane | 0,2670 - 25,6000 |
| Volume | |
| Media Volume | 2.827.954 |
| Capitalizzazione | 2,178M |
| Beta (5 anni mensile) | 0,44 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -705,6000 |
| Prossima data utili | N/D |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | 1,50 |
- GlobeNewswire
Aclarion Provides Updated Investor Presentation and Corporate Update
Aclarion is steadily executing on a proven path toward standard of care. Ten prominent Key Opinion Leader (KOL) surgeons have formally engaged to partner with the company to drive market traction and reimbursement. Company is poised to report the critical metrics that drive the key catalysts of value creation. BROOMFIELD, CO, Oct. 02, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveragin
- GlobeNewswire
Aclarion, Inc. Announces Filing of Delayed 10-Q Quarterly Report
BROOMFIELD, CO, Aug. 25, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, announced today that it was not able to file its Quarterly Report for the quarter ended June 30, 2023 by the August 21, 2023 extended filing deadline established by the Securities an
- GlobeNewswire
Aclarion Announces New Commercial Engagement with The Imaging Center, Grand Rapids, MI
BROOMFIELD, CO, June 14, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, announced today their commercial agreement with The Imaging Center in Grand Rapids, MI. The Imaging Center is a new medical imaging center in the greater Grand Rapids market serving ph
